Teodor Burtea - Institute Director Council

MRES Stock  USD 0.01  0.0004  4.04%   

Insider

Teodor Burtea is Director Council of Institute of Biomedical
Phone382 20 663 075
Webhttps://mrescorp.com

Similar Executives

Showing other executives

INSIDER Age

Eric TseSino Biopharmaceutical Ltd
27
Edith MDBolt Biotherapeutics
67
BSc FRCPathAchilles Therapeutics PLC
59
Simon BeaudoinDefence Therapeutics
39
Shachar CPAEnlivex Therapeutics
47
MBA CFABolt Biotherapeutics
60
MD FACPNextCure
71
Carrie CesaroneDefence Therapeutics
58
Sergio QuezadaAchilles Therapeutics PLC
49
Ming YinBolt Biotherapeutics
N/A
Michael MSBANextCure
63
Sebastien PlouffeDefence Therapeutics
51
Moutih RafeiDefence Therapeutics
41
Lieping MDNextCure
67
Solomon LangermannNextCure
64
FMEDSCI MDAchilles Therapeutics PLC
49
Julia WilsonAchilles Therapeutics PLC
N/A
CPA CPANextCure
61
Karl MDAchilles Therapeutics PLC
57
Oren HershkovitzEnlivex Therapeutics
47
Karen BergmanBolt Biotherapeutics
N/A
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada. Institute is traded on OTC Exchange in the United States. Institute of Biomedical [MRES] is a Pink Sheet which is traded between brokers as part of OTC trading.

Institute of Biomedical Leadership Team

Elected by the shareholders, the Institute's board of directors comprises two types of representatives: Institute inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Institute. The board's role is to monitor Institute's management team and ensure that shareholders' interests are well served. Institute's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Institute's outside directors are responsible for providing unbiased perspectives on the board's policies.
Teodor Burtea, Director Council
Drasko Pekovic, Chairman, Founder

Institute Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Institute a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Institute Pink Sheet Analysis

When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.